A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Clinical trial NCT01043172 · COMPLETED
Trial details
- NCT number
- NCT01043172
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-20
- Primary completion
- 2016-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.